Abstract
Background and objective Proton pump inhibitors (PPIs), which are used to treat gastroesophageal symptoms, can vary in price, but are thought not to differ in clinical benefits. Health Canada’s Non-Insured Health Benefits Program instituted a therapeutic substitution policy for PPIs as a cost-containment strategy in 2005. The objective of this pilot study was to identify signals of what might be occurring as a result of this policy in Aboriginal people in northern, isolated communities.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
